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Indigo carmine has been used for eight decades with few adverse effects. Several of our patients, however, 
experienced severe hypotensive episodes after indigo carmine administration within a period of one month. Analysis 
of the raw materials used to formulate the preparation of indigo carmine we used showed that they contained 
impurities. Following recall of these impure materials, none of our patients experienced further hypotensive 
episodes. (Korean J Anesthesiol 2011; 61: 435-438)
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Indigo carmine is a blue dye widely used in urologic and 
gynecologic procedures to identify ureteral patency. Although 
biologically inert, it occasionally causes side effects including 
nausea, hypertension [1], bradycardia [2], and supraventricular 
bigeminy [3]. Severe hypotension after indigo carmine injection 
is extremely uncommon, with only approximately 10 cases 
reported in the literature [4-8]. Few of the patients in our 
institution have experienced adverse reactions associated 
with indigo carmine administration, with most of these being 
mild hypertension and bradycardia. Recently, however, within 
a one month period, five of our patients experienced severe 
hypotension after administration of indigo carmine. We herein 
describe these patients and review the literature on causes of 
adverse reactions.
Case Report
A 69-year-old woman with a transitional cell carcinoma in 
the renal pelvis underwent a laparoscopic nephroureterectomy. 
The patient had a history of hypertension, and had no history 
of allergy or previous exposure to indigo carmine. Anesthesia 
was induced with thiopental 400 mg and vecuronium 10 mg, 
and maintained with 2% sevoflurane after tracheal intubation. 
A 20-gauge catheter was inserted into her left radial artery to 
monitor continuous arterial pressure. During the operation, 
the patient’s vital signs were stable, with blood pressure (BP) 
100-130/70-95 mmHg, heart rate 62-88 bpm, and SpO2 98-
100%. Two hundred minutes after the induction of anesthesia, 
she received a bolus injection of 40 mg indigo carmine (sodium 
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indigotindisulfonate; Korea United Pharm., Seoul, Korea). One 
minute later, her BP suddenly decreased from 120/85 mmHg 
to 50/30 mmHg, but heart rate remained at 80-90 bpm. There 
was no evidence of massive blood loss or electrocardiographic 
changes prior to the hypotensive episode, and there were no 
skin rashes, angioedema, or any sign of bronchospasm during 
the hypotensive episode. She was immediately administered 
ephedrine 20 mg and phenylephrine 0.3 mg, which restored her 
BP to 120/75 mmHg. Postoperatively her vital signs remained 
stable and she was discharged without any sequelae. Ten days 
later, a 73-year-old man who underwent a radical retropubic 
prostatectomy under general anesthesia experienced severe 
hypotension after administration of indigo carmine. Ninety 
minutes after anesthesia induction, he received an injection 
of 40 mg indigo carmine, and then BP decreased from 110/65 
mmHg to 60/35 mmHg without any skin rash or urticaria. He 
was administered ephedrine 40 mg and phenylephrine 0.3 
mg, which restored his BP to the pre-indigo carmine level. The 
patient’s postoperative course was uneventful.
Following these adverse events, we decided to dilute indigo 
carmine in normal saline and to administer it slowly over five 
minutes. Two days later, a 64-year-old woman underwent a 
partial nephrectomy. The patient had a drug allergy to Saridon-A 
(Roche Korea, Seoul, Korea), which contains acetaminophen, 
anhydrous caffeine, and isopropylantipyrine. Two hundred 
minutes after induction, she was administered 40 mg indigo 
carmine diluted in 20 ml of saline over five minutes. A sudden 
drop in BP was observed; from 125/72 mmHg to 45/30 mmHg, 
and injection of ephedrine 30 mg restored her BP within three 
minutes.
Following this third episode of hypotension, we suspected 
a manufacturing error and checked the lot number of indigo 
carmine. We discarded all of the indigo carmine with lot number 
001, used in our third patient, and decided to use another lot 
Fig. 1. Analytic results of liquid chromatography (left) and mass spectrometry (right). Genuine raw material used to manufacture indigo 
carmine (top) shows a single peak at 1.24 minutes in liquid chromatography and this peak shows three mass peaks representing mass fragment 
of indigo carmine in mass spectrometry. The raw material for the indigo carmine that caused the hypotensive episodes (bottom) shows 
bimodal curve on liquid chromatography. The peak at 1.24 minutes in liquid chromatography shows the same three mass peaks as genuine raw 
material (not shown). A second liquid chromatography peak, at 1.33 minutes, shows abnormal relative abundance value, m/z = 340, by mass 
spectrometry. This peak is likely due to a chain of SO3Na that came off one side of the indigo carmine structure.437 www.ekja.org
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number, 002. Two weeks later, two additional patients experienced 
severe hypotension following administration of indigo carmine. 
The first, a 68-year-old man, underwent transurethral bladder 
tumor resection under general anesthesia. Eighty minutes after 
induction of anesthesia, he was administered indigo carmine. 
Five minutes later, his BP dropped from 128/75 mmHg to 65/43 
mmHg, and injection of phenylephrine 0.3 mg restored his 
BP. Another patient was a 77-year-old man who underwent 
transurethral resection of the bladder. Spinal anesthesia was 
induced with hyperbaric bupivacaine 11 mg at the L4-5 level. 
After forty-five minutes, he received indigo carmine, and then 
his BP decreased from 110/65 mmHg to 60/35 mmHg. After 
administration of 15 mg ephedrine, his vital signs remained 
stable throughout the rest of the procedure. Both patients were 
discharged postoperatively without any particular sequelae.
Following these episodes, we asked the manufacturer about 
the indigo carmine we had used. The company’s director 
informed us that lot numbers 001 and 002 were manufactured 
with the same raw materials, and the manufacturer provided 
us with indigo carmine of lot number 906, which to date has 
not been associated with any such adverse events. The raw 
materials used to manufacture indigo carmines were analyzed, 
including their crystalline status, thermo-physiochemical 
properties and particle size distribution, all of which are 
required analytical criteria for drug manufacture, as determined 
by the Korea Food and Drug Administration. A comparison of 
the raw materials used to manufacture lot numbers 002 and 906 
showed no differences. Further analysis of the raw materials 
by liquid chromatography (LC) and mass spectrometry (MS) 
showed that, when compared with lot number 906, lot number 
002 had a separated peak on LC and an abnormal fragment 
peak on MS, suggesting the presence of impurities (Fig. 1). 
Based on these analytic results, all indigo carmine numbered as 
001 and 002 were recalled and its usage was restricted.
Discussion
The term anaphylaxis has been used for all types of acute 
life-threatening, generalized hypersensitivity reactions due to 
abnormal sensitivity to a triggering agent [9]. Although indigo 
carmine has no known activity in the human body, it has 
been found to directly activate alpha-adrenergic receptors, 
which may lead to reflex bradycardia and/or hypertension 
[10]. Hypotension after indigo carmine administration is an 
unexpected adverse effect and has been reported in fewer than 
10 patients over 80 years of use.
Sudden, severe hypotension after indigo carmine admini-
stration was first reported in a series of four patients with no 
known drug allergies who underwent radical prostatectomy 
under epidural anesthesia [5]. Due to the temporal association 
between indigo carmine injection and the hemodynamic 
change, an idiosyncratic drug reaction was considered the 
most plausible cause. Usually, indigo carmine might cause 
both stimulant and depressant effects simultaneously, 
however, those cases could be induced by unopposed depre-
ssant component under sympathetic blockade [11]. Severe 
hypotension, bronchospasm and urticaria after administration 
of indigo carmine were observed in a patient under general 
anesthesia [7]. That patient, who was undergoing transurethral 
resection of a bladder tumor, manifested the complete 
spectrum of anaphylaxis five minutes after injection of indigo 
carmine, including hemodynamic collapse, cutaneous 
changes, laryngeal edema and bronchospasm. Due to a lack 
of prior allergies or prior exposure to indigo carmine, their 
case was thought to be caused by histamine release such as 
an anaphylactoid reaction. Life-threatening adverse reaction 
associated with indigo carmine presenting as even asystole was 
reported [12]. Severe hypotension, bradycardia, hypoxia were 
observed after indigo carmine injection, and then the patient 
became asystolic. Following chest compression and intra-
aortic balloon pump support, the patient’s blood pressure was 
stabilized. The patient’s cardiac arrest event was believed to be 
due to an anaphylactoid reaction in response to indigo carmine. 
A diagnosis of anaphylaxis requires evidence of involvement 
of three or more organs and the detection of specific IgE or a 
positive skin test to the alleged agent. However, since these 
reports did not verify these findings, it would be reasonable 
to diagnose these events as idiosyncratic reactions, including 
anaphylaxis.
Compared with the previous reports, our patients had 
somewhat bizarre clinical manifestations. During the period 
described for all five patients, we used lot numbers 001 and 
002 of indigo carmine on 15 patients. However, hypotensive 
episodes requiring vasopressor occurred in only five patients. 
Hypotensive episodes in some of the other patients may have 
been overlooked because their symptoms were mild and they 
recovered immediately. In all five patients described above, 
saline replacement was adequate and there was no massive 
blood loss. There were no symptoms or signs suggesting 
anaphylactoid reactions, such as cutaneous changes or 
wheezing. Two patients who experienced hypotensive episodes 
were tested for hypersensitivity to indigo carmine of lot number 
002 by skin prick tests and intradermal skin tests, and both 
were negative. Although a negative response to a suspected 
agent is unreliable in ruling out drug hypersensitivity [13], the 
clinical manifestations of these patients indicate that drug 
hypersensitivity or anaphylaxis was unlikely causes.
We focused on the five patients who experienced hypotension 
serially within a one month period, and suspected that flaws 
in production were responsible for these adverse reactions. 438 www.ekja.org
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During the manufacturing process, indigo carmine molecules 
may be fragmented by accelerated electron beams, and these 
fragmented ions can be classified by their mass to charge 
(m/z) ratios on MS (Fig. 2). Analysis of the raw materials by 
LC/MS showed an abnormal peak in lot number 002 that was 
not present in lot number 906. This additional peak contained 
abnormal amounts of fragmented ions, with m/z = 340, which 
had not been filtered out during the manufacturing process. 
These impurities may have affected hemodynamic response 
after administration of indigo carmine.
Raw materials, reagents, and degradation during manufacture 
and storage are all possible sources of impurities in drugs [14]. 
These impure drugs may cause various adverse reactions, 
regardless of their pharmacological effects. Determining the 
lot number of the drug may be helpful in investigating the 
causes of adverse reactions. Usually, physicians tend to ignore 
or miss symptoms and signs if they are not critical. However, 
practitioners should always pay attention when using drugs 
and prevent further adverse drug reactions by meticulous 
monitoring and prompt reporting.
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Fig. 2. Structure of indigo carmine and its by-products during the 
manufacturing process. The term m/z represents mass to charge 
ratio, indicating the relationship between mass of an ion and its 
elementary charges.